Centogene N.V. 39K.F Stock
Centogene N.V. Price Chart
Centogene N.V. 39K.F Financial and Trading Overview
| Centogene N.V. stock price | 0.58 EUR |
| Previous Close | 0.74 EUR |
| Open | 0.75 EUR |
| Bid | 0.75 EUR x N/A |
| Ask | 0.76 EUR x N/A |
| Day's Range | 0.75 - 0.75 EUR |
| 52 Week Range | 0.54 - 2.65 EUR |
| Volume | 3.26K EUR |
| Avg. Volume | 1.35K EUR |
| Market Cap | 21.6M EUR |
| Beta (5Y Monthly) | -0.919888 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.45 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 20.97 EUR |
39K.F Valuation Measures
| Enterprise Value | 44.59M EUR |
| Trailing P/E | N/A |
| Forward P/E | -0.38358974 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.45493236 |
| Price/Book (mrq) | 2.7806692 |
| Enterprise Value/Revenue | 0.939 |
| Enterprise Value/EBITDA | -1.435 |
Trading Information
Centogene N.V. Stock Price History
| Beta (5Y Monthly) | -0.919888 |
| 52-Week Change | -66.95% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 2.65 EUR |
| 52 Week Low | 0.54 EUR |
| 50-Day Moving Average | 0.73 EUR |
| 200-Day Moving Average | 0.94 EUR |
39K.F Share Statistics
| Avg. Volume (3 month) | 1.35K EUR |
| Avg. Daily Volume (10-Days) | 1.26K EUR |
| Shares Outstanding | 27.6M |
| Float | 7.99M |
| Short Ratio | N/A |
| % Held by Insiders | 20.83% |
| % Held by Institutions | 65.63% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -67.072% |
| Operating Margin (ttm) | -75.67% |
| Gross Margin | 41.95% |
| EBITDA Margin | -65.46% |
Management Effectiveness
| Return on Assets (ttm) | -24.41% |
| Return on Equity (ttm) | -223.27% |
Income Statement
| Revenue (ttm) | 47.47M EUR |
| Revenue Per Share (ttm) | 1.77 EUR |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -31077000 EUR |
| Net Income Avi to Common (ttm) | -38703000 EUR |
| Diluted EPS (ttm) | -1.4 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 35.95M EUR |
| Total Cash Per Share (mrq) | 1.3 EUR |
| Total Debt (mrq) | 60.12M EUR |
| Total Debt/Equity (mrq) | 811.25 EUR |
| Current Ratio (mrq) | 2.426 |
| Book Value Per Share (mrq) | 0.269 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -26488000 EUR |
| Levered Free Cash Flow (ttm) | -21584250 EUR |
Profile of Centogene N.V.
| Country | Germany |
| State | N/A |
| City | Rostock |
| Address | Am Strande 7 |
| ZIP | 18055 |
| Phone | 49 381 80113 500 |
| Website | https://www.centogene.com |
| Industry | Diagnostics & Research |
| Sector(s) | Healthcare |
| Full Time Employees | 444 |
Centogene N.V., together with its subsidiaries, engages in the research and development of products for human genetics in Europe, the Middle East, North America, Latin America, and the Asia Pacific. It provides data-driven answers to patients, physicians, and pharmaceutical companies for rare and neurodegenerative diseases. It operates through two segments: Pharmaceutical and Diagnostics. The company provides target and drug screening, clinical development, market access and expansion, as well as CENTOGENE Biodatabank licenses and insight report services. In addition, it offers various services, including early patient recruitment and identification, epidemiological insights, biomarker discovery, and patient monitoring; and genetic sequencing and diagnostics services to physicians, laboratories, or hospitals directly or through distributors. Centogene N.V. was founded in 2006 and is headquartered in Rostock, Germany.
Q&A For Centogene N.V. Stock
What is a current 39K.F stock price?
Centogene N.V. 39K.F stock price today per share is 0.58 EUR.
How to purchase Centogene N.V. stock?
You can buy 39K.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Centogene N.V.?
The stock symbol or ticker of Centogene N.V. is 39K.F.
Which industry does the Centogene N.V. company belong to?
The Centogene N.V. industry is Diagnostics & Research.
How many shares does Centogene N.V. have in circulation?
The max supply of Centogene N.V. shares is 27.87M.
What is Centogene N.V. Price to Earnings Ratio (PE Ratio)?
Centogene N.V. PE Ratio is now.
What was Centogene N.V. earnings per share over the trailing 12 months (TTM)?
Centogene N.V. EPS is -1.45 EUR over the trailing 12 months.
Which sector does the Centogene N.V. company belong to?
The Centogene N.V. sector is Healthcare.